Sotabase

Career

· Staff Researcher, Canva2025–
· Associate Professor (tenured), 澳大利亚国立大学2024–
· Head Of AI, TRENDii2021–2025
· Senior Lecturer, 澳大利亚国立大学2021–2023
· Lecturer And CS Futures Fellow, The Australian National University2018–2021
· Postdoctoral Researcher, UTS: University of Technology Sydney2016–2018
· Postdoctoral Fellow, The University of Texas at San Antonio2015–2016
· PhD Electronic Engineering, Tsinghua University2010–2015

Publications (179)

Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Nature · 2013
3,300
cited
Person Re-identification in the Wild
Computer Vision and Pattern Recognition · 2016
740
cited
Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.
New England Journal of Medicine · 2014
428
cited
An inactivated enterovirus 71 vaccine in healthy children.
New England Journal of Medicine · 2014
362
cited
EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)
Expert Review of Vaccines · 2016
202
cited
Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide
Expert Review of Anti-Infective Therapy · 2015
195
cited
Impact of the Delta variant on vaccine efficacy and response strategies
Expert Review of Vaccines · 2021
194
cited
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
Expert Review of Vaccines · 2021
161
cited
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
Emerging Microbes and Infections · 2021
142
cited
Molecular Determinants of Enterovirus 71 Viral Entry
Journal of Biological Chemistry · 2012
130
cited
Coxsackievirus A16
Human Vaccines & Immunotherapeutics · 2014
125
cited
Research Advances on the Stability of mRNA Vaccines
Viruses · 2023
109
cited
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
Frontiers in Immunology · 2021
102
cited
EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
Emerging Microbes and Infections · 2016
93
cited
A Neonatal Mouse Model of Coxsackievirus A16 for Vaccine Evaluation
Journal of Virology · 2012
88
cited
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
Emerging Microbes and Infections · 2021
87
cited
Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines.
Vaccine · 2011
76
cited
The 6th AI City Challenge
2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW) · 2022
75
cited
Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine.
Vaccine · 2011
75
cited
Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems
Expert Review of Anti-Infective Therapy · 2019
72
cited
Sotabase